• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探索儿童针对呼吸道合胞病毒(RSV)和严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染的免疫反应。

Exploring the Immune Response against RSV and SARS-CoV-2 Infection in Children.

作者信息

da Silva Rafaela Pires, Thomé Bibiana Liberman, da Souza Ana Paula Duarte

机构信息

Laboratory of Clinical and Experimental Immunology, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre 90619-900, Brazil.

出版信息

Biology (Basel). 2023 Sep 9;12(9):1223. doi: 10.3390/biology12091223.

DOI:10.3390/biology12091223
PMID:37759622
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10525162/
Abstract

Viral respiratory tract infections are a significant public health concern, particularly in children. RSV is a prominent cause of lower respiratory tract infections among infants, whereas SARS-CoV-2 has caused a global pandemic with lower overall severity in children than in adults. In this review, we aimed to compare the innate and adaptive immune responses induced by RSV and SARS-CoV-2 to better understand differences in the pathogenesis of infection. Some studies have demonstrated that children present a more robust immune response against SARS-CoV-2 than adults; however, this response is dissimilar to that of RSV. Each virus has a distinctive mechanism to escape the immune response. Understanding the mechanisms underlying these differences is crucial for developing effective treatments and improving the management of pediatric respiratory infections.

摘要

病毒性呼吸道感染是一个重大的公共卫生问题,在儿童中尤为如此。呼吸道合胞病毒(RSV)是婴儿下呼吸道感染的一个主要病因,而严重急性呼吸综合征冠状病毒2(SARS-CoV-2)已引发全球大流行,儿童感染后的总体严重程度低于成人。在本综述中,我们旨在比较RSV和SARS-CoV-2诱导的先天性和适应性免疫反应,以更好地了解感染发病机制的差异。一些研究表明,儿童对SARS-CoV-2的免疫反应比成人更强;然而,这种反应与RSV不同。每种病毒都有独特的逃避免疫反应的机制。了解这些差异背后的机制对于开发有效的治疗方法和改善儿科呼吸道感染的管理至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff4d/10525162/eb6b5214fca1/biology-12-01223-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff4d/10525162/579d5cf048a5/biology-12-01223-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff4d/10525162/eb6b5214fca1/biology-12-01223-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff4d/10525162/579d5cf048a5/biology-12-01223-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff4d/10525162/eb6b5214fca1/biology-12-01223-g002a.jpg

相似文献

1
Exploring the Immune Response against RSV and SARS-CoV-2 Infection in Children.探索儿童针对呼吸道合胞病毒(RSV)和严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染的免疫反应。
Biology (Basel). 2023 Sep 9;12(9):1223. doi: 10.3390/biology12091223.
2
The Human Nose Organoid Respiratory Virus Model: an Human Challenge Model To Study Respiratory Syncytial Virus (RSV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pathogenesis and Evaluate Therapeutics.人呼吸道类器官病毒模型:用于研究呼吸道合胞病毒(RSV)和严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)发病机制及评估治疗方法的人体挑战模型。
mBio. 2021 Feb 22;13(1):e0351121. doi: 10.1128/mbio.03511-21. Epub 2022 Feb 15.
3
Clinical Differences between SARS-CoV-2 and RSV Infections in Infants: Findings from a Case-Control Study.婴儿中 SARS-CoV-2 和 RSV 感染的临床差异:一项病例对照研究的结果。
Viruses. 2023 Dec 30;16(1):63. doi: 10.3390/v16010063.
4
Age-related Differences in the Nasal Mucosal Immune Response to SARS-CoV-2.年龄相关的 SARS-CoV-2 鼻黏膜免疫反应差异。
Am J Respir Cell Mol Biol. 2022 Feb;66(2):206-222. doi: 10.1165/rcmb.2021-0292OC.
5
Human Nasal and Lung Tissues Infected with SARS-CoV-2 Provide Insights into Differential Tissue-Specific and Virus-Specific Innate Immune Responses in the Upper and Lower Respiratory Tract.人鼻腔和肺部组织感染 SARS-CoV-2 提供了在上呼吸道和下呼吸道中不同组织特异性和病毒特异性先天免疫反应的见解。
J Virol. 2021 Jun 24;95(14):e0013021. doi: 10.1128/JVI.00130-21.
6
A differential regulatory T cell signature distinguishes the immune landscape of COVID-19 hospitalized patients from those hospitalized with other respiratory viral infections.一种差异性调节性T细胞特征可区分新冠病毒肺炎住院患者与其他呼吸道病毒感染住院患者的免疫格局。
medRxiv. 2021 Mar 26:2021.03.25.21254376. doi: 10.1101/2021.03.25.21254376.
7
Depletion of TAX1BP1 Amplifies Innate Immune Responses during Respiratory Syncytial Virus Infection.TAX1BP1 耗竭增强呼吸道合胞病毒感染期间固有免疫反应。
J Virol. 2021 Oct 27;95(22):e0091221. doi: 10.1128/JVI.00912-21. Epub 2021 Aug 25.
8
Assessing respiratory viral exclusion and affinity interactions through co-infection incidence in a pediatric population during the 2022 resurgence of influenza and RSV.评估 2022 年流感和 RSV 再次流行期间儿科人群中合并感染发生率的呼吸道病毒排除和亲和相互作用。
Front Cell Infect Microbiol. 2023 Jun 14;13:1208235. doi: 10.3389/fcimb.2023.1208235. eCollection 2023.
9
A delayed resurgence of respiratory syncytial virus (RSV) during the COVID-19 pandemic: An unpredictable outbreak in a small proportion of children in the Southwest of Iran, April 2022.2022 年 4 月,伊朗西南部一小部分儿童出现了 COVID-19 大流行期间呼吸道合胞病毒(RSV)的延迟反弹:一次不可预测的暴发。
J Med Virol. 2022 Dec;94(12):5802-5807. doi: 10.1002/jmv.28065. Epub 2022 Aug 23.
10
Immune response to SARS-CoV-2 in the nasal mucosa in children and adults.儿童和成人鼻黏膜对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的免疫反应。
medRxiv. 2021 Jan 28:2021.01.26.21250269. doi: 10.1101/2021.01.26.21250269.

引用本文的文献

1
Immunomodulation in Respiratory Syncytial Virus Infection: Mechanisms, Therapeutic Targets, and Clinical Implications.呼吸道合胞病毒感染中的免疫调节:机制、治疗靶点及临床意义
Microorganisms. 2025 Aug 12;13(8):1876. doi: 10.3390/microorganisms13081876.
2
Differential NF-κB mRNA Expression in Blood and Buccal Mucosa of Pediatric Patients with RSV Bronchiolitis.呼吸道合胞病毒细支气管炎患儿血液和颊黏膜中NF-κB mRNA的差异表达
Genes (Basel). 2025 Jul 22;16(8):851. doi: 10.3390/genes16080851.
3
Case Report: Pediatric respiratory viral infection failure: a case series of eight fatalities in children under 5 years old in Iran.

本文引用的文献

1
Interferons in COVID-19: missed opportunities to prove efficacy in clinical phase III trials?新冠疫情中的干扰素:错失在III期临床试验中证明疗效的机会?
Front Med (Lausanne). 2023 May 30;10:1198576. doi: 10.3389/fmed.2023.1198576. eCollection 2023.
2
Neutrophil sub-types in maintaining immune homeostasis during steady state, infections and sterile inflammation.中性粒细胞亚群在稳态、感染和无菌性炎症期间维持免疫稳态中的作用。
Inflamm Res. 2023 Jun;72(6):1175-1192. doi: 10.1007/s00011-023-01737-9. Epub 2023 May 22.
3
Dual domain recognition determines SARS-CoV-2 PLpro selectivity for human ISG15 and K48-linked di-ubiquitin.
病例报告:小儿呼吸道病毒感染失败:伊朗5岁以下儿童八例死亡病例系列
Front Pediatr. 2025 May 9;13:1396142. doi: 10.3389/fped.2025.1396142. eCollection 2025.
4
Impact of Respiratory Syncytial Virus and Severe Acute Respiratory Syndrome Coronavirus 2 Coinfection on Clinical Severity and Outcomes Among Children Hospitalized With Lower Respiratory Tract Infections in Soweto, South Africa.呼吸道合胞病毒与严重急性呼吸综合征冠状病毒2合并感染对南非索韦托下呼吸道感染住院儿童临床严重程度及预后的影响
Pediatr Infect Dis J. 2025 Feb 1;44(2):107-111. doi: 10.1097/INF.0000000000004560. Epub 2024 Oct 2.
5
Immune Response to Respiratory Viral Infections.呼吸道病毒感染的免疫反应。
Int J Mol Sci. 2024 Jun 4;25(11):6178. doi: 10.3390/ijms25116178.
双结构域识别决定了 SARS-CoV-2 PLpro 对人 ISG15 和 K48 连接的二泛素的选择性。
Nat Commun. 2023 Apr 25;14(1):2366. doi: 10.1038/s41467-023-38031-5.
4
Trained immunity: A "new" weapon in the fight against infectious diseases.训练免疫:对抗传染病的“新”武器。
Front Immunol. 2023 Mar 13;14:1147476. doi: 10.3389/fimmu.2023.1147476. eCollection 2023.
5
Early Treatment with Pegylated Interferon Lambda for Covid-19.聚乙二醇干扰素 λ 早期治疗 COVID-19。
N Engl J Med. 2023 Feb 9;388(6):518-528. doi: 10.1056/NEJMoa2209760.
6
SARS-CoV-2 NSP7 inhibits type I and III IFN production by targeting the RIG-I/MDA5, TRIF, and STING signaling pathways.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)非结构蛋白7(NSP7)通过靶向视黄酸诱导基因I(RIG-I)/黑色素瘤分化相关基因5(MDA5)、TIR结构域衔接蛋白诱导干扰素β(TRIF)和干扰素基因刺激蛋白(STING)信号通路来抑制I型和III型干扰素的产生。
J Med Virol. 2023 Mar;95(3):e28561. doi: 10.1002/jmv.28561.
7
Update on the treatment of multisystem inflammatory syndrome in children associated with COVID-19.新型冠状病毒肺炎相关儿童多系统炎症综合征的治疗进展
Future Virol. 2022 Dec. doi: 10.2217/fvl-2022-0048. Epub 2023 Jan 19.
8
Tracking the clonal dynamics of SARS-CoV-2-specific T cells in children and adults with mild/asymptomatic COVID-19.追踪 SARS-CoV-2 特异性 T 细胞在儿童和轻症/无症状 COVID-19 成人患者中的克隆动力学。
Clin Immunol. 2023 Jan;246:109209. doi: 10.1016/j.clim.2022.109209. Epub 2022 Dec 17.
9
Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children.儿童 SARS-CoV-2 相关多系统炎症综合征中的 OAS-RNase L 先天性错误。
Science. 2023 Feb 10;379(6632):eabo3627. doi: 10.1126/science.abo3627.
10
Adaptive immune responses to SARS-CoV-2 persist in the pharyngeal lymphoid tissue of children.儿童咽淋巴组织中存在针对 SARS-CoV-2 的适应性免疫应答。
Nat Immunol. 2023 Jan;24(1):186-199. doi: 10.1038/s41590-022-01367-z. Epub 2022 Dec 19.